Cargando…
Systemic inflammation response index predicts 3-month outcome in patients with mild acute ischemic stroke receiving intravenous thrombolysis
INTRODUCTION: A crucial aspect of stroke progression is the inflammatory response. As novel inflammatory and prognostic markers, the systemic immune inflammation index (SII) and the systemic inflammation response index (SIRI) have recently been studied. The objective of our study was to evaluate the...
Autores principales: | Chu, Min, Luo, Yunhe, Wang, Daosheng, Liu, Yang, Wang, Delong, Wang, Yong, Zhao, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9946296/ https://www.ncbi.nlm.nih.gov/pubmed/36846118 http://dx.doi.org/10.3389/fneur.2023.1095668 |
Ejemplares similares
-
Characteristics and Outcomes of Intravenous Thrombolysis in Mild Ischemic Stroke Patients
por: Tang, Huan, et al.
Publicado: (2021) -
Intravenous Thrombolysis in Ischemic Stroke Patients With Active Cancer
por: Selvik, Henriette Aurora, et al.
Publicado: (2018) -
Impact of homocysteine levels on clinical outcome in patients with acute ischemic stroke receiving intravenous thrombolysis therapy
por: Li, Lei, et al.
Publicado: (2020) -
Stress Hyperglycemia Does Not Affect Clinical Outcome of Diabetic Patients Receiving Intravenous Thrombolysis for Acute Ischemic Stroke
por: Merlino, Giovanni, et al.
Publicado: (2022) -
Dual Antiplatelet Therapy in Patients With Minor Stroke Receiving Intravenous Thrombolysis
por: Xu, Zhaohan, et al.
Publicado: (2022)